SHEZF (Shenzhen Hepalink Pharmaceutical Group Co) Cyclically Adjusted Book per Share: $0.31 (As of Mar. 2026)


SHEZF Shenzhen Hepalink Pharmaceutical Group Co Ltd SHEZF
70 GF Score
Price $0.47
GF Value $0.55
! 7 Warning Signs
View Full Analysis

What is Shenzhen Hepalink Pharmaceutical Group Co Cyclically Adjusted Book per Share?

Shenzhen Hepalink Pharmaceutical Group Co SHEZF 70 Cyclically Adjusted Book per Share is $0.31 as of Mar. 2026. GuruFocus rates SHEZF with a GF Score™ of 70/100 and a GF Value™ of $0.55. The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Shenzhen Hepalink Pharmaceutical Group Co's adjusted book value per share for the three months ended in Mar. 2026 was $1.204. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.31 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Shenzhen Hepalink Pharmaceutical Group Co's average Cyclically Adjusted Book Growth Rate was 2.00% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 1.40% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 1.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Shenzhen Hepalink Pharmaceutical Group Co was 3.70% per year. The lowest was 1.40% per year. And the median was 2.00% per year.

As of today (2026-07-04), Shenzhen Hepalink Pharmaceutical Group Co's current stock price is $0.4696. Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was $0.31. Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted PB Ratio of today is 1.51.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Shenzhen Hepalink Pharmaceutical Group Co was 4.36. The lowest was 1.05. And the median was 2.21.


Shenzhen Hepalink Pharmaceutical Group Co  (OTCPK:SHEZF) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.4696/0.31
=1.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Shenzhen Hepalink Pharmaceutical Group Co was 4.36. The lowest was 1.05. And the median was 2.21.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Shenzhen Hepalink Pharmaceutical Group Co Cyclically Adjusted Book per Share Related Terms


Shenzhen Hepalink Pharmaceutical Group Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shenzhen Hepalink Pharmaceutical Group Co Cyclically Adjusted Book per Share Chart

Shenzhen Hepalink Pharmaceutical Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.61 0.40 0.45 0.32 0.30

Shenzhen Hepalink Pharmaceutical Group Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.31 0.29 0.29 0.30 0.31

SHEZF vs ZTS, UTHR: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shenzhen Hepalink Pharmaceutical Group Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted PB Ratio falls into.


SHEZF
70GF Score
Shenzhen Hepalink Pharmaceutical Group Co Ltd SHEZF
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shenzhen Hepalink Pharmaceutical Group Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Shenzhen Hepalink Pharmaceutical Group Co's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1.204/116.3000*116.3000
=1.204

Current CPI (Mar. 2026) = 116.3000.

Shenzhen Hepalink Pharmaceutical Group Co Quarterly Data

Book Value per Share CPI Adj_Book
201606 0.955 101.400 1.095
201609 0.960 102.400 1.090
201612 0.924 102.600 1.047
201703 0.930 103.200 1.048
201706 0.886 103.100 0.999
201709 0.920 104.100 1.028
201712 0.946 104.500 1.053
201803 0.951 105.300 1.050
201806 0.947 104.900 1.050
201809 0.683 106.600 0.745
201812 0.710 106.500 0.775
201903 0.790 107.700 0.853
201906 0.764 107.700 0.825
201909 0.770 109.800 0.816
201912 0.840 111.200 0.879
202003 0.875 112.300 0.906
202006 0.878 110.400 0.925
202009 1.126 111.700 1.172
202012 1.206 111.500 1.258
202103 1.227 112.662 1.267
202106 1.233 111.769 1.283
202109 1.236 112.215 1.281
202112 1.221 113.108 1.255
202203 1.250 114.335 1.271
202206 1.225 114.558 1.244
202209 1.200 115.339 1.210
202212 1.204 115.116 1.216
202303 1.224 115.116 1.237
202306 1.180 114.558 1.198
202309 1.159 115.339 1.169
202312 1.137 114.781 1.152
202403 1.142 115.227 1.153
202406 1.140 114.781 1.155
202409 1.169 115.785 1.174
202412 1.137 114.893 1.151
202503 1.155 115.116 1.167
202506 1.154 114.907 1.168
202509 1.183 115.470 1.192
202512 1.164 115.830 1.169
202603 1.204 116.300 1.204

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $0.31 mean?
Shenzhen Hepalink Pharmaceutical Group Co (SHEZF) has a Cyclically Adjusted Book per Share of $0.31 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Shenzhen Hepalink Pharmaceutical Group Co and its competitors.
Is Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted Book per Share too high?
Shenzhen Hepalink Pharmaceutical Group Co's current Cyclically Adjusted Book per Share is $0.31. Overall, Shenzhen Hepalink Pharmaceutical Group Co has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted Book per Share of $0.31 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Shenzhen Hepalink Pharmaceutical Group Co and its competitors. Shenzhen Hepalink Pharmaceutical Group Co's current Cyclically Adjusted Book per Share is $0.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shenzhen Hepalink Pharmaceutical Group Co stock overvalued right now?
Shenzhen Hepalink Pharmaceutical Group Co (SHEZF) has a current Cyclically Adjusted Book per Share of $0.31. The stock's GF Value™ is $0.55, compared to a current price of $0.47 — trading 14.6% below its estimated fair value. The current Cyclically Adjusted Book per Share is $0.31. Shenzhen Hepalink Pharmaceutical Group Co's overall GF Score™ is 70/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Shenzhen Hepalink Pharmaceutical Group Co (SHEZF), the current Cyclically Adjusted Book per Share is $0.31 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shenzhen Hepalink Pharmaceutical Group Co (SHEZF) Overvalued in 2026?

Based on GuruFocus' analysis, Shenzhen Hepalink Pharmaceutical Group Co stock appears to be undervalued. The current stock price of $0.47 is trading 14.6% below its estimated GF Value™ of $0.55.

Key valuation signals for SHEZF:

  • Cyclically Adjusted Book per Share: $0.31
  • GF Value™: $0.55 vs. price of $0.47 (14.6% below fair value)
  • GF Score™: 70/100 with 7 warning signs

No single metric tells the full story. See the SHEZF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shenzhen Hepalink Pharmaceutical Group Co Business Description

Other Exchanges 09989:Hong Kong002399:China
Address No. 21 Langshan Road, Songping Mountain, Guangdong Province, Nanshan District, Shenzhen, CHN, 518057
Shenzhen Hepalink Pharmaceutical Group Co Ltd is a China-based company. Along with its subsidiary, it is engaged in biopharmaceutical production, biopharmaceutical services, biopharmaceutical trading, and biopharmaceutical research and development in Asia, Europe, North America, and Australia, and investment business in Asia and North America. The Group mainly operates three main business segments, including the Finished dose pharmaceutical products; Active pharmaceutical ingredients; CDMO business; and Others. The geographical presence of the company is in Hong Kong, the United States of America, Europe, Mainland China, and Other countries. The majority of the company's revenue comes from Europe and the USA.
70GF Score

Get the complete analysis for SHEZF

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.47
Price
$0.55
GF Value